VYNE Therapeutics (VYNE) S-4/A Registration of securities issued in business combination transactions (amended)

Exhibit 23.2

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in this Amendment No. 1 to the Registration Statement on FormS-4 of Menlo Therapeutics Inc. of our report dated February 28, 2019 relating to the financial statements, which appears in Foamix Pharmaceuticals Ltd.’s Annual Report on Form10-K for the year ended December 31, 2018. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

Tel-Aviv, Israel	/s/ Kesselman & Kesselman
January 6, 2020	Certified Public Accountants (Isr.)
	A member firm of PricewaterhouseCoopers International Limited

Kesselman & Kesselman, Trade Tower, 25 Hamered Street,Tel-Aviv 6812508, Israel,

    P.O Box 50005Tel-Aviv 6150001 Telephone: +972-3- 7954555, Fax:+972-3- 7954556,

    www.pwc.com/il